tiprankstipranks
Advertisement
Advertisement

WAT Stock Latest News

Notable companies reporting before tomorrow’s open
The FlyNotable companies reporting before tomorrow’s open
13h ago
DD
IT
Is WAT a Buy, Before Earnings?
PremiumPre-Earnings
Is WAT a Buy, Before Earnings?
2d ago
WAT
Waters price target lowered to $330 from $370 at UBS
PremiumThe Fly
Waters price target lowered to $330 from $370 at UBS
22d ago
WAT
Waters announces FDA clearance of Onclarity HPV Self-Collection Kit
PremiumThe Fly
Waters announces FDA clearance of Onclarity HPV Self-Collection Kit
27d ago
WAT
Waters upgraded to Outperform from In Line at Evercore ISI
PremiumThe Fly
Waters upgraded to Outperform from In Line at Evercore ISI
29d ago
WAT
Waters reinstated with a Buy at Goldman Sachs
PremiumThe FlyWaters reinstated with a Buy at Goldman Sachs
1M ago
WAT
Waters price target lowered to $330 from $370 at Deutsche Bank
Premium
The Fly
Waters price target lowered to $330 from $370 at Deutsche Bank
1M ago
WAT
Waters Subsidiary Completes $3.5 Billion Senior Notes Offering
Premium
Company Announcements
Waters Subsidiary Completes $3.5 Billion Senior Notes Offering
1M ago
8K
WAT
Waters director buys $144.7K in common stock
PremiumThe Fly
Waters director buys $144.7K in common stock
2M ago
WAT
Waters Details Financial Impact of Recent SpinCo Acquisition
PremiumCompany Announcements
Waters Details Financial Impact of Recent SpinCo Acquisition
2M ago
8K
WAT
Waters price target lowered to $350 from $423 at Morgan Stanley
PremiumThe Fly
Waters price target lowered to $350 from $423 at Morgan Stanley
2M ago
WAT
Waters Corporation: Hold Rating Maintained as BD Acquisitions Temper Medium‑Term Growth and Drive Target Cut to $350
PremiumRatings
Waters Corporation: Hold Rating Maintained as BD Acquisitions Temper Medium‑Term Growth and Drive Target Cut to $350
2M ago
WAT
Buy Rating Reaffirmed on Temporary Headwinds and Credible Turnaround Path Post-BD Acquisition
PremiumRatingsBuy Rating Reaffirmed on Temporary Headwinds and Credible Turnaround Path Post-BD Acquisition
3M ago
WAT
Waters price target lowered to $370 from $395 at UBS
Premium
The Fly
Waters price target lowered to $370 from $395 at UBS
3M ago
WAT
Waters price target lowered to $363 from $398 at Baird
Premium
The Fly
Waters price target lowered to $363 from $398 at Baird
3M ago
WAT
Waters price target lowered to $373 from $400 at TD Cowen
PremiumThe Fly
Waters price target lowered to $373 from $400 at TD Cowen
3M ago
WAT
Waters resumed with an In Line at Evercore ISI
PremiumThe Fly
Waters resumed with an In Line at Evercore ISI
3M ago
BDX
WAT
Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
PremiumRatings
Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside
3M ago
WAT
Waters price target lowered to $350 from $410 at BofA
PremiumThe Fly
Waters price target lowered to $350 from $410 at BofA
3M ago
WAT
Waters reinstated with an Overweight at Barclays
PremiumThe FlyWaters reinstated with an Overweight at Barclays
3M ago
WAT
Waters resumed with a Buy at Citi
Premium
The Fly
Waters resumed with a Buy at Citi
3M ago
WAT
Waters Corp Earnings Call: Growth, Risks and Synergies
Premium
Company Announcements
Waters Corp Earnings Call: Growth, Risks and Synergies
3M ago
WAT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >